Free Trial
→ Altucher: It Looks Like My Trump prediction is coming true (From Paradigm Press) (Ad)tc pixel Free MCHP Stock Alerts

Microchip Technology (MCHP) Financials

Microchip Technology logo
$65.00 -0.25 (-0.38%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$65.07 +0.07 (+0.11%)
As of 08/29/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Microchip Technology

Annual Income Statements for Microchip Technology

This table shows Microchip Technology's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 369 324 165 255 356 571 349 1,286 2,238 1,907 -2.70
Consolidated Net Income / (Loss)		 365 324 165 255 356 571 349 1,286 2,238 1,907 -0.50
Net Income / (Loss) Continuing Operations		 365 324 171 255 356 571 349 1,286 2,238 1,907 -0.50
Total Pre-Tax Income 		346 281 90 737 205 150 340 1,483 2,910 2,366 39
Total Operating Income		 426 352 276 936 714 647 998 1,850 3,116 2,571 296
Total Gross Profit		 1,230 1,206 1,757 2,421 2,931 3,242 3,379 4,450 5,698 4,996 2,468
Total Revenue		 2,147 2,173 3,408 3,981 5,350 5,274 5,438 6,821 8,439 7,634 4,402
Operating Revenue		 2,147 2,173 3,408 3,981 5,350 5,274 5,438 6,821 8,439 7,634 4,402
Total Cost of Revenue		 917 968 1,651 1,560 2,418 2,032 2,060 2,371 2,741 2,639 1,934
Operating Cost of Revenue		 917 968 1,651 1,560 2,418 2,032 2,060 2,371 2,741 2,639 1,934
Total Operating Expenses		 804 853 1,481 1,484 2,217 2,595 2,381 2,600 2,582 2,425 2,172
Selling, General & Admin Expense		 275 302 500 452 683 677 610 719 798 734 618
Research & Development Expense		 350 373 545 529 826 878 836 989 1,118 1,097 984
Amortization Expense		 177 175 338 486 674 994 932 863 670 605 491
Other Special Charges / (Income)		 2.84 4.00 99 18 34 47 1.70 30 -4.00 -12 79
Total Other Income / (Expense), net		 -80 -71 -186 -199 -510 -497 -659 -367 -206 -205 -257
Interest Expense		 113 104 190 215 516 503 657 370 212 211 261
Interest & Investment Income		 19 24 2.90 22 7.90 2.80 1.70 0.50 2.10 7.60 9.20
Other Income / (Expense), net		 14 8.90 1.30 -5.80 -2.20 3.20 -3.80 2.80 3.80 -2.20 -5.70
Income Tax Expense		 -19 -43 -81 482 -151 -420 -9.90 197 672 459 39
Preferred Stock Dividends Declared		 - - - - - - - - 0.00 0.00 2.20
Basic Earnings per Share		 $1.84 $1.59 $0.76 $1.10 $1.51 $1.19 $0.67 $2.33 $4.07 $3.52 ($0.01)
Weighted Average Basic Shares Outstanding		 200.94M 203.40M 217.20M 232.90M 236.20M 477.70M 519.20M 552.30M 550.40M 542M 537.30M
Diluted Earnings per Share		 $1.65 $1.49 $0.71 $1.03 $1.42 $1.11 $0.65 $2.27 $4.02 $3.48 ($0.01)
Weighted Average Diluted Shares Outstanding		 223.56M 217.40M 234.80M 248.90M 249.90M 512.40M 541.20M 565.90M 557.30M 548M 537.30M
Weighted Average Basic & Diluted Shares Outstanding		 200.50M 203.90M 216.60M 232.20M 235.70M 245.33M 273.53M 554.50M 545.38M 536.89M 539.40M
Cash Dividends to Common per Share		 $1.43 $1.43 $1.44 $1.45 $1.46 $0.73 $0.75 $0.91 $1.26 $1.68 $1.82

Quarterly Income Statements for Microchip Technology

This table shows Microchip Technology's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 580 604 666 667 419 155 129 78 -54 -157 -46
Consolidated Net Income / (Loss)		 580 604 666 667 419 155 129 78 -54 -155 -19
Net Income / (Loss) Continuing Operations		 580 604 666 667 419 155 129 78 -54 -155 -19
Total Pre-Tax Income 		762 802 848 834 484 200 162 92 -46 -168 -16
Total Operating Income		 812 848 903 885 529 254 219 147 31 -100 32
Total Gross Profit		 1,471 1,519 1,558 1,527 1,120 790 737 669 561 501 577
Total Revenue		 2,169 2,233 2,289 2,254 1,766 1,326 1,241 1,164 1,026 971 1,076
Operating Revenue		 2,169 2,233 2,289 2,254 1,766 1,326 1,241 1,164 1,026 971 1,076
Total Cost of Revenue		 698 713 730 727 646 536 504 495 465 469 499
Operating Cost of Revenue		 698 713 730 727 646 536 504 495 465 469 499
Total Operating Expenses		 659 671 655 642 591 536 518 522 531 601 545
Selling, General & Admin Expense		 203 204 204 197 172 162 151 157 158 152 159
Research & Development Expense		 282 298 299 293 266 240 242 241 246 255 256
Amortization Expense		 167 167 152 151 151 151 123 123 123 123 108
Other Special Charges / (Income)		 6.50 2.10 1.70 1.80 1.10 -17 2.60 1.50 3.50 72 22
Total Other Income / (Expense), net		 -49 -46 -55 -51 -45 -54 -57 -55 -77 -68 -48
Interest Expense		 53 48 56 50 49 55 62 59 69 71 57
Interest & Investment Income		 0.80 1.00 1.50 1.60 2.00 2.50 2.80 2.00 1.70 2.70 4.90
Other Income / (Expense), net		 2.60 0.30 0.00 -3.10 2.10 -1.20 1.70 2.00 -9.70 0.30 4.60
Income Tax Expense		 182 198 182 167 65 45 33 13 7.50 -14 2.80
Preferred Stock Dividends Declared		 - - - - - - 0.00 - - - 28
Basic Earnings per Share		 $1.06 $1.10 $1.22 $1.23 $0.78 $0.29 $0.24 $0.15 ($0.10) ($0.30) ($0.09)
Weighted Average Basic Shares Outstanding		 549.20M 550.40M 545.10M 543.10M 540.80M 542M 536.70M 536.70M 537.40M 537.30M 539.20M
Diluted Earnings per Share		 $1.04 $1.10 $1.21 $1.21 $0.77 $0.29 $0.24 $0.14 ($0.10) ($0.29) ($0.09)
Weighted Average Diluted Shares Outstanding		 555.40M 557.30M 551.40M 549.20M 546.50M 548M 542.80M 542M 537.40M 537.30M 539.20M
Weighted Average Basic & Diluted Shares Outstanding		 547.80M 545.38M 544.33M 541.05M 540.39M 536.89M 536.51M 537.01M 537.82M 539.40M 539.68M
Cash Dividends to Common per Share		 $0.33 $0.36 $0.38 $0.41 $0.44 $0.45 $0.45 $0.45 $0.46 $0.46 $0.46

Annual Cash Flow Statements for Microchip Technology

This table details how cash moves in and out of Microchip Technology's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -1,062 196 -1,183 -7.40 -473 -28 -121 37 -83 86 452
Net Cash From Operating Activities		 378 468 1,060 1,420 1,675 1,544 1,917 2,843 3,621 2,893 898
Net Cash From Continuing Operating Activities		 378 468 1,060 1,420 1,669 1,544 1,917 2,843 3,621 2,893 898
Net Income / (Loss) Continuing Operations		 0.00 0.00 165 255 356 571 349 1,286 2,238 1,907 -0.50
Consolidated Net Income / (Loss)		 - - 165 255 356 571 349 1,286 2,238 1,907 -0.50
Depreciation Expense		 278 283 469 616 876 1,216 1,153 1,144 998 880 750
Amortization Expense		 17 52 61 113 131 139 88 56 17 45 73
Non-Cash Adjustments To Reconcile Net Income		 109 71 197 120 183 176 492 327 181 192 182
Changes in Operating Assets and Liabilities, net		 -27 61 168 316 123 -557 -166 31 188 -130 -106
Net Cash From Investing Activities		 -678 800 -2,838 -1,012 -6,811 -133 -173 -478 -600 -392 -288
Net Cash From Continuing Investing Activities		 0.00 14 -2,838 -1,012 -6,811 -133 -173 -478 -600 -392 -288
Purchase of Property, Plant & Equipment		 - - -86 -214 -248 -139 -182 -492 -600 -399 -291
Other Investing Activities, net		 - - - - - - - 0.00 0.90 6.40 2.80
Net Cash From Financing Activities		 99 -60 596 -415 4,664 -1,438 -1,864 -2,328 -3,105 -2,415 -158
Net Cash From Continuing Financing Activities		 -1,439 -286 596 -415 4,664 -1,438 -1,864 -2,328 -3,105 -2,415 -158
Repayment of Debt		 -1,167 -2.20 -3,255 -75 -4,368 -2,716 -8,979 -6,557 -7,405 -17,596 -17,629
Repurchase of Common Equity		 - - - - - 0.00 0.00 -426 -946 -982 -97
Payment of Dividends		 -286 -291 -315 -338 -344 -350 -388 -504 -695 -912 -976
Issuance of Debt		 0.00 0.00 4,182 0.00 9,406 1,638 7,544 5,173 5,935 17,055 17,248
Issuance of Preferred Equity		 - - - - - - - - 0.00 0.00 1,450
Issuance of Common Equity		 34 29 42 42 43 59 60 71 82 82 65
Other Financing Activities, net		 -20 -22 -58 -44 -73 -69 -101 -85 -77 -63 -219
Cash Interest Paid		 - - - 85 348 355 - - 182 191 236
Cash Income Taxes Paid		 - - - 26 78 101 - - 483 517 175

Quarterly Cash Flow Statements for Microchip Technology

This table details how cash moves in and out of Microchip Technology's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents		 -16 -55 37 -15 24 39 -4.60 -29 300 186 -205
Net Cash From Operating Activities		 1,278 710 993 616 853 430 377 44 272 206 276
Net Cash From Continuing Operating Activities		 1,278 710 993 616 853 430 377 44 272 206 276
Net Income / (Loss) Continuing Operations		 580 604 666 667 419 155 129 78 -54 -155 -19
Consolidated Net Income / (Loss)		 580 604 666 667 419 155 129 78 -54 -155 -19
Depreciation Expense		 244 243 223 219 219 218 189 188 187 187 171
Amortization Expense		 4.20 4.20 3.90 4.90 16 20 19 14 25 15 2.80
Non-Cash Adjustments To Reconcile Net Income		 48 44 54 49 45 43 44 46 -76 168 55
Changes in Operating Assets and Liabilities, net		 402 -186 46 -323 154 -6.50 -3.50 -283 189 -9.30 65
Net Cash From Investing Activities		 -164 -151 -141 -94 -86 -71 -126 -64 -42 -56 -37
Net Cash From Continuing Investing Activities		 -164 -151 -141 -94 -86 -71 -126 -64 -42 -56 -37
Purchase of Property, Plant & Equipment		 -164 -151 -141 -94 -87 -76 -126 -67 -42 -56 -42
Other Investing Activities, net		 - - 0.00 0.40 1.10 4.90 0.10 2.40 -0.10 0.40 4.80
Net Cash From Financing Activities		 -1,130 -614 -815 -537 -743 -320 -256 -8.40 71 36 -444
Net Cash From Continuing Financing Activities		 -1,130 -614 -815 -537 -743 -320 -256 -8.40 71 36 -444
Repayment of Debt		 -1,975 -2,067 -3,050 -4,696 -2,954 -6,896 -4,653 -2,534 -5,883 -4,559 -177
Repurchase of Common Equity		 -230 -274 -140 -340 -115 -387 -73 -17 -6.50 - 0.00
Payment of Dividends		 -180 -196 -209 -223 -237 -243 -243 -244 -245 -245 -271
Issuance of Debt		 1,256 1,914 2,585 4,711 2,563 7,196 4,823 2,781 6,205 3,438 0.00
Issuance of Common Equity		 17 28 15 25 17 24 13 21 12 20 12
Other Financing Activities, net		 -17 -19 -16 -15 -17 -15 -124 -15 -12 -68 -8.80

Annual Balance Sheets for Microchip Technology

This table presents Microchip Technology's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Total Assets		 4,781 5,538 7,687 8,257 18,350 17,426 16,479 16,200 16,370 15,873 15,375
Total Current Assets		 2,665 3,097 2,305 3,356 2,215 2,217 2,145 2,453 3,069 3,013 2,991
Cash & Equivalents		 608 2,093 909 901 429 401 280 317 234 320 772
Accounts Receivable		 274 290 478 564 881 934 998 1,073 1,305 1,144 690
Inventories, net		 279 307 417 476 712 686 665 854 1,325 1,316 1,294
Other Current Assets		 47 12 59 120 192 195 201 206 205 234 236
Plant, Property, & Equipment, net		 582 609 683 768 997 876 855 968 1,178 1,195 1,184
Total Noncurrent Assets		 1,535 1,832 4,699 4,133 15,139 14,333 13,479 12,779 12,123 11,666 11,200
Goodwill		 571 1,013 2,299 2,299 6,664 6,665 6,671 6,674 6,674 6,675 6,685
Intangible Assets		 504 606 2,148 1,662 6,686 5,702 4,795 4,043 3,369 2,782 2,389
Noncurrent Deferred & Refundable Income Taxes		 0.00 15 69 100 1,677 1,749 1,749 1,797 1,623 1,597 1,728
Other Noncurrent Operating Assets		 76 79 75 72 112 217 264 265 457 612 398
Total Liabilities & Shareholders' Equity		 4,781 5,538 7,687 8,257 18,350 17,426 16,479 16,200 16,370 15,873 15,375
Total Liabilities		 2,720 3,387 4,416 4,977 13,063 11,841 11,142 10,305 9,857 9,215 8,296
Total Current Liabilities		 354 382 705 2,017 2,375 1,637 2,410 1,399 3,119 2,519 1,155
Accounts Payable		 87 79 149 144 226 247 292 345 397 213 161
Accrued Expenses		 101 119 213 230 787 782 794 1,054 1,324 1,307 995
Total Noncurrent Liabilities		 2,366 3,005 3,712 2,960 10,688 10,203 8,732 8,906 6,738 6,696 7,141
Long-Term Debt		 1,827 2,453 2,901 1,758 8,946 8,873 7,581 7,687 5,042 5,000 5,630
Noncurrent Deferred Revenue		 114 111 185 755 756 668 690 705 706 649 633
Noncurrent Deferred & Payable Income Tax Liabilities		 381 399 409 206 706 319 44 40 43 29 34
Other Noncurrent Operating Liabilities		 43 41 217 241 280 343 417 474 948 1,018 844
Total Equity & Noncontrolling Interests		 2,045 2,151 3,271 3,280 5,288 5,586 5,337 5,895 6,514 6,658 7,078
Total Preferred & Common Equity		 2,045 2,151 3,271 3,280 5,288 5,586 5,337 5,895 6,514 6,658 7,078
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 2,045 2,151 3,271 3,280 5,288 5,586 5,337 5,895 6,514 6,658 7,078
Common Stock		 1,000 1,392 2,538 2,563 2,680 2,675 2,404 2,537 2,414 2,483 3,911
Retained Earnings		 1,550 1,583 1,479 1,397 3,211 3,432 3,394 4,175 5,764 6,760 5,781
Treasury Stock		 -516 -820 -732 -663 -582 -501 -434 -796 -1,660 -2,582 -2,612
Accumulated Other Comprehensive Income / (Loss)		 11 -3.36 -14 -18 -21 -22 -26 -21 -4.10 -3.50 -1.70

Quarterly Balance Sheets for Microchip Technology

This table presents Microchip Technology's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 6/30/2025
Total Assets		 16,141 16,116 16,370 16,495 16,601 16,143 15,873 15,840 15,622 15,632 14,980
Total Current Assets		 2,676 2,834 3,069 3,270 3,526 3,220 3,013 2,948 2,906 2,996 2,754
Cash & Equivalents		 305 289 234 271 257 281 320 315 286 586 567
Accounts Receivable		 1,133 1,175 1,305 1,465 1,706 1,398 1,144 1,096 1,044 857 766
Inventories, net		 1,030 1,165 1,325 1,336 1,331 1,311 1,316 1,308 1,340 1,356 1,169
Other Current Assets		 206 204 205 197 233 229 234 229 236 196 253
Plant, Property, & Equipment, net		 1,088 1,114 1,178 1,186 1,207 1,208 1,195 1,196 1,171 1,152 1,154
Total Noncurrent Assets		 12,377 12,169 12,123 12,039 11,868 11,715 11,666 11,695 11,546 11,484 11,072
Goodwill		 6,674 6,674 6,674 6,675 6,675 6,675 6,675 6,682 6,682 6,685 6,695
Intangible Assets		 3,705 3,545 3,369 3,253 3,089 2,937 2,782 2,776 2,655 2,518 2,292
Noncurrent Deferred & Refundable Income Taxes		 1,692 1,630 1,623 1,604 1,576 1,538 1,597 1,601 1,638 1,704 1,735
Other Noncurrent Operating Assets		 306 320 457 507 528 565 612 637 572 577 350
Total Liabilities & Shareholders' Equity		 16,141 16,116 16,370 16,495 16,601 16,143 15,873 15,840 15,622 15,632 14,980
Total Liabilities		 10,038 9,805 9,857 9,663 9,633 9,063 9,215 9,434 9,346 9,601 8,122
Total Current Liabilities		 2,538 1,611 3,119 3,220 3,413 3,293 2,519 1,520 3,286 1,330 1,190
Accounts Payable		 380 355 397 281 284 242 213 196 204 196 162
Accrued Expenses		 1,160 1,256 1,324 1,540 1,468 1,389 1,307 1,324 1,135 1,134 1,029
Total Noncurrent Liabilities		 7,500 8,193 6,738 6,444 6,220 5,770 6,696 7,913 6,061 8,270 6,932
Long-Term Debt		 6,305 6,589 5,042 4,632 4,415 4,033 5,000 6,168 4,477 6,750 5,458
Noncurrent Deferred Revenue		 667 660 706 719 679 635 649 656 590 599 640
Noncurrent Deferred & Payable Income Tax Liabilities		 42 40 43 42 34 33 29 32 30 23 36
Other Noncurrent Operating Liabilities		 486 904 948 1,050 1,093 1,068 1,018 1,058 964 899 797
Total Equity & Noncontrolling Interests		 6,103 6,312 6,514 6,831 6,969 7,080 6,658 6,406 6,276 6,032 6,857
Total Preferred & Common Equity		 6,103 6,312 6,514 6,831 6,969 7,080 6,658 6,406 6,276 6,032 6,857
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 6,103 6,312 6,514 6,831 6,969 7,080 6,658 6,406 6,276 6,032 6,857
Common Stock		 2,356 2,381 2,414 2,401 2,415 2,446 2,483 2,405 2,446 2,482 3,975
Retained Earnings		 4,956 5,356 5,764 6,222 6,666 6,847 6,760 6,646 6,481 6,183 5,489
Treasury Stock		 -1,197 -1,408 -1,660 -1,787 -2,109 -2,209 -2,582 -2,641 -2,643 -2,630 -2,600
Accumulated Other Comprehensive Income / (Loss)		 -12 -18 -4.10 -4.40 -2.80 -4.80 -3.50 -3.70 -7.80 -3.30 -6.40

Annual Metrics And Ratios for Microchip Technology

This table displays calculated financial ratios and metrics derived from Microchip Technology's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 11.18% 1.22% 56.80% 16.81% 34.38% -1.41% 3.11% 25.42% 23.72% -9.53% -42.35%
EBITDA Growth		 10.54% -5.24% 15.87% 105.65% 3.62% 16.59% 11.53% 36.52% 35.47% -15.52% -68.13%
EBIT Growth		 -5.47% -17.79% -23.28% 235.80% -23.47% -8.68% 52.90% 86.30% 68.42% -17.66% -88.69%
NOPAT Growth		 7.15% -9.76% 29.16% -38.10% 283.29% 97.49% -58.16% 56.13% 49.42% -13.53% -100.18%
Net Income Growth		 -7.58% -11.34% -49.18% 55.16% 39.35% 60.33% -38.77% 267.92% 74.07% -14.78% -100.03%
EPS Growth		 -9.34% -9.70% -52.35% 45.07% 37.86% 60.33% -38.77% 249.23% 77.09% -13.43% -100.29%
Operating Cash Flow Growth		 45.51% 23.89% 126.53% 33.99% 17.98% -7.82% 24.14% 48.33% 27.38% -20.11% -68.95%
Free Cash Flow Firm Growth		 -102.54% -1,184.88% -1,305.39% 143.62% -1,099.55% 130.24% -41.34% 32.75% 27.80% -16.53% -83.82%
Invested Capital Growth		 45.61% 38.32% 135.54% -13.59% 265.26% -3.29% -4.81% -4.99% -4.10% -3.00% -3.25%
Revenue Q/Q Growth		 2.38% 0.67% 11.27% 2.57% 6.52% -0.06% 2.66% 5.85% 4.83% -10.62% -7.47%
EBITDA Q/Q Growth		 5.08% -5.62% 21.85% 7.20% 9.63% -2.78% 4.79% 8.61% 6.20% -14.76% -25.89%
EBIT Q/Q Growth		 0.41% -11.94% 38.75% 8.75% 9.88% -16.75% 16.80% 15.01% 10.62% -18.83% -54.80%
NOPAT Q/Q Growth		 8.29% -14.74% 94.50% -3.11% 35.88% 26.20% -12.74% 18.79% 6.22% -17.54% -100.77%
Net Income Q/Q Growth		 -3.41% -8.80% 73.15% 4.00% 8.54% -11.59% 4.83% 33.41% 8.02% -19.07% -100.16%
EPS Q/Q Growth		 -4.07% -8.02% 86.84% -0.96% 2.16% -11.59% 4.83% 30.46% 6.63% -20.18% -101.75%
Operating Cash Flow Q/Q Growth		 14.78% 24.15% 59.88% 2.67% 2.69% -2.01% 4.21% 11.73% -1.04% -8.81% -19.97%
Free Cash Flow Firm Q/Q Growth		 -115.48% 38.90% 13.19% -9.55% 3.40% 22.18% -9.12% 11.71% -2.04% -6.69% -49.92%
Invested Capital Q/Q Growth		 5.47% -4.46% -3.63% -2.08% -0.68% -0.88% -0.75% -0.70% 0.86% -1.25% -2.12%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 57.27% 55.47% 51.56% 60.81% 54.80% 61.47% 62.13% 65.23% 67.52% 65.44% 56.07%
EBITDA Margin		 34.23% 32.04% 23.68% 41.69% 32.14% 38.01% 41.11% 44.75% 49.00% 45.75% 25.29%
Operating Margin		 19.82% 16.21% 8.09% 23.52% 13.35% 12.27% 18.35% 27.12% 36.93% 33.68% 6.73%
EBIT Margin		 20.46% 16.62% 8.13% 23.37% 13.31% 12.33% 18.28% 27.16% 36.97% 33.65% 6.60%
Profit (Net Income) Margin		 17.02% 14.90% 4.83% 6.42% 6.65% 10.82% 6.42% 18.85% 26.52% 24.98% -0.01%
Tax Burden Percent		 105.61% 115.14% 183.30% 34.64% 174.03% 379.39% 102.92% 86.71% 76.90% 80.60% -1.29%
Interest Burden Percent		 78.73% 77.88% 32.41% 79.24% 28.72% 23.13% 34.14% 80.03% 93.27% 92.10% 13.39%
Effective Tax Rate		 -5.61% -15.14% -89.98% 65.36% -74.03% -279.39% -2.92% 13.29% 23.10% 19.40% 101.29%
Return on Invested Capital (ROIC)		 36.14% 23.09% 15.31% 7.24% 12.87% 16.46% 7.18% 11.78% 18.45% 16.54% -0.03%
ROIC Less NNEP Spread (ROIC-NNEP)		 46.09% 47.09% -35.21% 1.51% -3.64% -3.42% -0.48% 7.80% 16.11% 13.76% 0.03%
Return on Net Nonoperating Assets (RNNOA)		 -18.66% -7.65% -9.24% 0.56% -4.56% -5.97% -0.78% 11.11% 17.62% 12.42% 0.02%
Return on Equity (ROE)		 17.48% 15.44% 6.07% 7.80% 8.31% 10.50% 6.40% 22.89% 36.07% 28.96% -0.01%
Cash Return on Invested Capital (CROIC)		 -1.00% -9.07% -65.48% 21.83% -101.15% 19.81% 12.11% 16.90% 22.63% 19.59% 3.27%
Operating Return on Assets (OROA)		 9.93% 7.00% 4.19% 11.67% 5.35% 3.64% 5.87% 11.34% 19.16% 15.93% 1.86%
Return on Assets (ROA)		 8.26% 6.28% 2.49% 3.20% 2.68% 3.19% 2.06% 7.87% 13.74% 11.83% 0.00%
Return on Common Equity (ROCE)		 17.48% 15.44% 6.07% 7.80% 8.31% 10.50% 6.40% 22.89% 36.07% 28.96% -0.01%
Return on Equity Simple (ROE_SIMPLE)		 17.87% 15.06% 5.03% 7.79% 6.73% 10.22% 6.55% 21.81% 34.35% 28.64% -0.01%
Net Operating Profit after Tax (NOPAT)		 450 406 524 324 1,243 2,455 1,027 1,604 2,396 2,072 -3.81
NOPAT Margin		 20.94% 18.67% 15.38% 8.15% 23.24% 46.55% 18.89% 23.51% 28.40% 27.14% -0.09%
Net Nonoperating Expense Percent (NNEP)		 -9.95% -24.00% 50.52% 5.73% 16.51% 19.88% 7.66% 3.98% 2.34% 2.78% -0.06%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - - -0.03%
Cost of Revenue to Revenue		 42.73% 44.53% 48.44% 39.19% 45.20% 38.53% 37.87% 34.77% 32.48% 34.56% 43.93%
SG&A Expenses to Revenue		 12.80% 13.88% 14.67% 11.36% 12.77% 12.83% 11.22% 10.54% 9.45% 9.62% 14.03%
R&D to Revenue		 16.28% 17.14% 16.00% 13.30% 15.45% 16.64% 15.38% 14.50% 13.25% 14.37% 22.35%
Operating Expenses to Revenue		 37.44% 39.26% 43.47% 37.29% 41.44% 49.20% 43.78% 38.12% 30.60% 31.76% 49.34%
Earnings before Interest and Taxes (EBIT)		 439 361 277 931 712 650 994 1,852 3,120 2,569 291
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 735 696 807 1,659 1,719 2,005 2,236 3,052 4,135 3,493 1,113
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.03 3.94 4.32 5.87 3.40 2.70 7.37 6.76 6.83 7.21 3.65
Price to Tangible Book Value (P/TBV)		 8.50 15.91 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 3.84 3.89 4.14 4.84 3.36 2.86 7.24 5.84 5.27 6.29 5.87
Price to Earnings (P/E)		 22.32 26.12 85.74 75.38 50.53 26.45 112.63 30.98 19.89 25.16 0.00
Dividend Yield		 3.49% 3.45% 2.21% 1.76% 1.92% 2.33% 1.02% 1.27% 1.55% 1.89% 3.78%
Earnings Yield		 4.48% 3.83% 1.17% 1.33% 1.98% 3.78% 0.89% 3.23% 5.03% 3.97% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 5.24 4.10 3.26 4.85 1.84 1.65 3.44 3.56 3.99 4.35 2.57
Enterprise Value to Revenue (EV/Rev)		 3.60 3.84 4.59 5.06 5.21 4.58 8.82 6.92 6.01 7.03 6.97
Enterprise Value to EBITDA (EV/EBITDA)		 10.51 11.99 19.40 12.13 16.20 12.06 21.46 15.46 12.26 15.36 27.57
Enterprise Value to EBIT (EV/EBIT)		 17.57 23.13 56.49 21.63 39.13 37.17 48.25 25.47 16.25 20.89 105.62
Enterprise Value to NOPAT (EV/NOPAT)		 17.18 20.59 29.88 62.04 22.41 9.85 46.71 29.42 21.16 25.90 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 20.45 17.86 14.77 14.18 16.64 15.66 25.03 16.60 14.00 18.55 34.18
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 20.59 0.00 8.18 27.69 20.52 17.25 21.87 77.30
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.89 1.14 0.90 0.94 1.95 1.70 1.67 1.30 0.99 0.90 0.80
Long-Term Debt to Equity		 0.89 1.14 0.89 0.54 1.69 1.59 1.42 1.30 0.77 0.75 0.80
Financial Leverage		 -0.41 -0.16 0.26 0.37 1.25 1.74 1.62 1.42 1.09 0.90 0.77
Leverage Ratio		 2.12 2.46 2.44 2.43 3.11 3.29 3.10 2.91 2.62 2.45 2.27
Compound Leverage Factor		 1.67 1.92 0.79 1.93 0.89 0.76 1.06 2.33 2.45 2.25 0.30
Debt to Total Capital		 47.19% 53.28% 47.43% 48.33% 66.09% 62.93% 62.52% 56.60% 49.72% 47.40% 44.30%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.80% 20.63% 8.73% 4.04% 9.29% 0.00% 10.79% 7.90% 0.00%
Long-Term Debt to Total Capital		 47.19% 53.28% 46.62% 27.70% 57.37% 58.89% 53.23% 56.60% 38.92% 39.51% 44.30%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 52.81% 46.72% 52.57% 51.67% 33.91% 37.07% 37.48% 43.40% 50.28% 52.60% 55.70%
Debt to EBITDA		 2.49 3.52 3.66 1.85 5.99 4.73 3.98 2.52 1.56 1.72 5.06
Net Debt to EBITDA		 -0.70 -0.16 1.91 0.53 5.74 4.53 3.86 2.41 1.50 1.63 4.36
Long-Term Debt to EBITDA		 2.49 3.52 3.59 1.06 5.20 4.43 3.39 2.52 1.22 1.43 5.06
Debt to NOPAT		 4.06 6.05 5.63 9.46 8.29 3.86 8.67 4.79 2.69 2.90 -1,478.38
Net Debt to NOPAT		 -1.15 -0.27 2.94 2.69 7.94 3.70 8.39 4.59 2.59 2.74 -1,275.76
Long-Term Debt to NOPAT		 4.06 6.05 5.54 5.42 7.20 3.61 7.38 4.79 2.10 2.41 -1,478.38
Altman Z-Score		 3.60 3.10 3.00 3.61 1.48 1.51 2.92 3.56 4.34 4.77 2.89
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 7.53 8.11 3.27 1.66 0.93 1.35 0.89 1.75 0.98 1.20 2.59
Quick Ratio		 6.31 7.16 2.53 1.37 0.55 0.82 0.53 1.00 0.49 0.58 1.27
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -12 -159 -2,241 977 -9,769 2,954 1,733 2,300 2,940 2,454 397
Operating Cash Flow to CapEx		 0.00% 0.00% 1,695.20% 697.25% 677.23% 1,135.98% 1,105.89% 595.08% 604.00% 726.63% 309.05%
Free Cash Flow to Firm to Interest Expense		 -0.11 -1.53 -11.78 4.55 -18.95 5.88 2.64 6.21 13.85 11.66 1.52
Operating Cash Flow to Interest Expense		 3.35 4.50 5.57 6.60 3.25 3.07 2.92 7.67 17.06 13.74 3.44
Operating Cash Flow Less CapEx to Interest Expense		 3.35 4.63 5.24 5.66 2.77 2.80 2.66 6.39 14.24 11.85 2.33
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.49 0.42 0.52 0.50 0.40 0.29 0.32 0.42 0.52 0.47 0.28
Accounts Receivable Turnover		 8.32 7.71 8.87 7.64 7.41 5.81 5.63 6.59 7.10 6.23 4.80
Inventory Turnover		 3.38 3.30 4.56 3.49 4.07 2.91 3.05 3.12 2.52 2.00 1.48
Fixed Asset Turnover		 3.86 3.65 5.27 5.49 6.06 5.63 6.28 7.48 7.87 6.44 3.70
Accounts Payable Turnover		 11.40 11.65 14.45 10.64 13.05 8.59 7.64 7.44 7.39 8.65 10.35
Days Sales Outstanding (DSO)		 43.89 47.37 41.16 47.78 49.27 62.79 64.82 55.39 51.43 58.54 76.02
Days Inventory Outstanding (DIO)		 107.85 110.55 80.05 104.51 89.65 125.50 119.68 116.94 145.11 182.65 246.28
Days Payable Outstanding (DPO)		 32.01 31.34 25.27 34.31 27.96 42.50 47.78 49.03 49.38 42.18 35.26
Cash Conversion Cycle (CCC)		 119.73 126.59 95.95 117.97 110.96 145.79 136.73 123.30 147.16 199.01 287.04
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,475 2,040 4,805 4,152 15,164 14,665 13,959 13,263 12,720 12,338 11,937
Invested Capital Turnover		 1.73 1.24 1.00 0.89 0.55 0.35 0.38 0.50 0.65 0.61 0.36
Increase / (Decrease) in Invested Capital		 462 565 2,765 -653 11,012 -499 -706 -696 -543 -382 -401
Enterprise Value (EV)		 7,721 8,353 15,654 20,123 27,861 24,174 47,977 47,190 50,705 53,667 30,695
Market Capitalization		 8,236 8,464 14,114 19,251 17,985 15,094 39,355 39,822 44,499 47,987 25,836
Book Value per Share		 $10.15 $10.57 $15.11 $14.00 $22.31 $23.32 $19.82 $10.60 $11.89 $12.32 $13.16
Tangible Book Value per Share		 $4.81 $2.61 ($5.44) ($2.91) ($34.02) ($28.31) ($22.76) ($8.67) ($6.44) ($5.18) ($3.71)
Total Capital		 3,872 4,604 6,221 6,348 15,595 15,068 14,241 13,582 12,954 12,658 12,709
Total Debt		 1,827 2,453 2,951 3,068 10,307 9,482 8,904 7,687 6,440 6,000 5,630
Total Long-Term Debt		 1,827 2,453 2,901 1,758 8,946 8,873 7,581 7,687 5,042 5,000 5,630
Net Debt		 -515 -111 1,540 872 9,876 9,079 8,622 7,368 6,206 5,680 4,859
Capital Expenditures (CapEx)		 0.00 -14 63 204 247 136 173 478 600 398 291
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 352 269 348 452 770 786 777 734 1,115 1,173 1,065
Debt-free Net Working Capital (DFNWC)		 2,311 2,715 1,651 2,649 1,201 1,189 1,059 1,054 1,349 1,493 1,836
Net Working Capital (NWC)		 2,311 2,715 1,601 1,339 -160 580 -264 1,054 -49 494 1,836
Net Nonoperating Expense (NNE)		 84 82 359 69 887 1,884 678 318 159 165 -3.31
Net Nonoperating Obligations (NNO)		 -570 -111 1,534 872 9,876 9,079 8,622 7,368 6,206 5,680 4,859
Total Depreciation and Amortization (D&A)		 296 335 530 729 1,007 1,354 1,242 1,200 1,015 924 823
Debt-free, Cash-free Net Working Capital to Revenue		 16.38% 12.36% 10.20% 11.36% 14.40% 14.90% 14.28% 10.76% 13.21% 15.37% 24.18%
Debt-free Net Working Capital to Revenue		 107.62% 124.91% 48.43% 66.54% 22.45% 22.54% 19.46% 15.45% 15.98% 19.56% 41.72%
Net Working Capital to Revenue		 107.62% 124.91% 46.97% 33.63% -2.99% 10.99% -4.86% 15.45% -0.58% 6.47% 41.72%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.92 $0.80 $0.38 $0.55 $0.76 $1.20 $0.68 $2.33 $4.07 $3.52 ($0.01)
Adjusted Weighted Average Basic Shares Outstanding		 401.87M 406.77M 434.39M 465.80M 472.40M 477.80M 519.20M 552.30M 550.40M 542M 537.30M
Adjusted Diluted Earnings per Share		 $0.83 $0.75 $0.36 $0.52 $0.71 $1.12 $0.65 $2.27 $4.02 $3.48 ($0.01)
Adjusted Weighted Average Diluted Shares Outstanding		 447.12M 434.78M 469.61M 497.80M 499.80M 512.40M 541.20M 565.90M 557.30M 548M 537.30M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.76 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 404.65M 429.63M 458.80M 470.07M 475.85M 490.66M 547.06M 554.50M 545.38M 536.89M 539.40M
Normalized Net Operating Profit after Tax (NOPAT)		 300 249 262 668 524 486 700 1,629 2,393 2,062 263
Normalized NOPAT Margin		 13.97% 11.48% 7.69% 16.77% 9.79% 9.21% 12.87% 23.89% 28.36% 27.01% 5.97%
Pre Tax Income Margin		 16.11% 12.94% 2.64% 18.52% 3.82% 2.85% 6.24% 21.73% 34.48% 30.99% 0.88%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 3.90 3.47 1.46 4.33 1.38 1.29 1.51 5.00 14.70 12.20 1.11
NOPAT to Interest Expense		 3.99 3.90 2.75 1.51 2.41 4.88 1.56 4.33 11.29 9.84 -0.01
EBIT Less CapEx to Interest Expense		 3.90 3.61 1.13 3.38 0.90 1.02 1.25 3.71 11.88 10.31 0.00
NOPAT Less CapEx to Interest Expense		 3.99 4.04 2.43 0.56 1.93 4.61 1.30 3.04 8.47 7.95 -1.13
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 78.42% 89.87% 191.62% 132.15% 96.77% 61.36% 111.13% 39.19% 31.07% 47.80% -195,140.00%
Augmented Payout Ratio		 78.42% 89.87% 191.62% 132.15% 96.77% 61.36% 111.13% 72.30% 73.34% 99.30% -214,440.00%

Quarterly Metrics And Ratios for Microchip Technology

This table displays calculated financial ratios and metrics derived from Microchip Technology's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 23.43% 21.07% 16.55% 8.74% -18.60% -40.62% -45.76% -48.37% -41.89% -26.80% -13.36%
EBITDA Growth		 27.43% 28.26% 16.91% 9.45% -27.84% -55.21% -62.11% -68.35% -69.57% -79.24% -50.81%
EBIT Growth		 56.70% 54.57% 28.46% 16.92% -34.72% -70.26% -75.55% -83.15% -96.01% -139.64% -83.38%
NOPAT Growth		 50.15% 27.22% 28.97% 19.96% -25.84% -69.26% -75.32% -82.25% -95.28% -135.75% -87.17%
Net Income Growth		 64.48% 37.93% 31.39% 22.04% -27.76% -74.39% -80.60% -88.24% -112.79% -199.94% -114.39%
EPS Growth		 67.74% 39.24% 34.44% 23.47% -25.96% -73.64% -80.17% -88.43% -112.99% -200.00% -137.50%
Operating Cash Flow Growth		 49.74% -5.11% 18.18% -22.31% -33.23% -39.39% -62.03% -92.92% -68.18% -52.12% -26.92%
Free Cash Flow Firm Growth		 21.62% -1.37% 10.92% -10.41% -57.81% -51.11% -60.40% -50.91% -44.14% -42.78% 4.98%
Invested Capital Growth		 -5.58% -4.10% -4.34% -2.38% -0.93% -3.00% -2.64% -2.93% -2.40% -3.25% -4.16%
Revenue Q/Q Growth		 4.63% 2.93% 2.50% -1.50% -21.67% -24.91% -6.37% -6.24% -11.84% -5.41% 10.82%
EBITDA Q/Q Growth		 5.16% 3.13% 3.12% -2.13% -30.67% -35.98% -12.78% -18.24% -33.34% -56.32% 106.67%
EBIT Q/Q Growth		 7.94% 4.19% 6.46% -2.35% -39.73% -52.53% -12.49% -32.70% -85.73% -571.70% 136.70%
NOPAT Q/Q Growth		 4.74% 3.38% 11.06% -0.25% -35.25% -57.15% -10.84% -28.26% -82.78% -424.60% 132.00%
Net Income Q/Q Growth		 6.24% 4.08% 10.33% 0.03% -37.11% -63.10% -16.42% -39.37% -168.37% -188.43% 87.97%
EPS Q/Q Growth		 6.12% 5.77% 10.00% 0.00% -36.36% -62.34% -17.24% -41.67% -171.43% -190.00% 68.97%
Operating Cash Flow Q/Q Growth		 61.11% -44.48% 39.99% -37.96% 38.48% -49.61% -12.30% -88.44% 522.71% -24.16% 33.85%
Free Cash Flow Firm Q/Q Growth		 19.72% -13.26% 8.38% -20.40% -43.61% 0.51% -12.23% -1.32% -35.83% 2.94% 61.05%
Invested Capital Q/Q Growth		 -3.73% 0.86% -1.01% 1.56% -2.29% -1.25% -0.64% 1.26% -1.75% -2.12% -1.58%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 67.80% 68.05% 68.09% 67.76% 63.43% 59.58% 59.37% 57.44% 54.72% 51.63% 53.62%
EBITDA Margin		 48.98% 49.08% 49.37% 49.05% 43.42% 37.02% 34.49% 30.07% 22.74% 10.50% 19.58%
Operating Margin		 37.41% 37.98% 39.46% 39.26% 29.98% 19.12% 17.65% 12.60% 3.01% -10.33% 2.98%
EBIT Margin		 37.53% 37.99% 39.46% 39.12% 30.10% 19.03% 17.79% 12.77% 2.07% -10.30% 3.41%
Profit (Net Income) Margin		 26.75% 27.05% 29.12% 29.57% 23.74% 11.67% 10.42% 6.74% -5.22% -15.93% -1.73%
Tax Burden Percent		 76.13% 75.33% 78.56% 79.97% 86.56% 77.47% 79.91% 85.68% 116.27% 91.86% 117.72%
Interest Burden Percent		 93.61% 94.52% 93.93% 94.52% 91.12% 79.15% 73.28% 61.57% -217.45% 168.30% -43.05%
Effective Tax Rate		 23.87% 24.67% 21.44% 20.03% 13.44% 22.53% 20.09% 14.32% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 17.66% 18.59% 21.10% 21.69% 17.66% 9.03% 7.48% 4.71% 0.81% -2.62% 0.74%
ROIC Less NNEP Spread (ROIC-NNEP)		 17.12% 18.07% 20.43% 21.05% 16.99% 8.32% 6.69% 3.92% -0.49% -4.23% -0.03%
Return on Net Nonoperating Assets (RNNOA)		 19.57% 19.77% 20.65% 20.64% 14.86% 7.51% 5.87% 3.54% -0.43% -3.24% -0.02%
Return on Equity (ROE)		 37.24% 38.35% 41.75% 42.34% 32.52% 16.54% 13.35% 8.25% 0.38% -5.87% 0.72%
Cash Return on Invested Capital (CROIC)		 23.11% 22.63% 24.29% 23.07% 20.95% 19.59% 15.06% 10.58% 6.42% 3.27% 4.89%
Operating Return on Assets (OROA)		 18.79% 19.69% 21.15% 21.37% 15.94% 9.01% 7.25% 4.36% 0.62% -2.90% 0.94%
Return on Assets (ROA)		 13.39% 14.02% 15.61% 16.16% 12.57% 5.53% 4.24% 2.30% -1.56% -4.49% -0.48%
Return on Common Equity (ROCE)		 37.24% 38.35% 41.75% 42.34% 32.52% 16.54% 13.35% 8.25% 0.38% -5.87% 0.72%
Return on Equity Simple (ROE_SIMPLE)		 32.82% 0.00% 35.09% 36.12% 33.28% 0.00% 21.38% 12.45% 5.12% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 618 639 709 708 458 196 175 126 22 -70 22
NOPAT Margin		 28.49% 28.61% 31.00% 31.39% 25.95% 14.81% 14.11% 10.79% 2.11% -7.23% 2.09%
Net Nonoperating Expense Percent (NNEP)		 0.54% 0.51% 0.67% 0.64% 0.67% 0.70% 0.79% 0.79% 1.30% 1.60% 0.76%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - 3.59% - - - 0.17% -0.55% 0.18%
Cost of Revenue to Revenue		 32.20% 31.95% 31.91% 32.25% 36.57% 40.42% 40.63% 42.56% 45.28% 48.37% 46.38%
SG&A Expenses to Revenue		 9.35% 9.11% 8.90% 8.72% 9.75% 12.20% 12.12% 13.49% 15.42% 15.66% 14.81%
R&D to Revenue		 13.02% 13.36% 13.04% 12.98% 15.06% 18.12% 19.47% 20.68% 24.00% 26.30% 23.76%
Operating Expenses to Revenue		 30.39% 30.07% 28.63% 28.50% 33.45% 40.46% 41.71% 44.84% 51.71% 61.97% 50.64%
Earnings before Interest and Taxes (EBIT)		 814 848 903 882 532 252 221 149 21 -100 37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,062 1,096 1,130 1,106 767 491 428 350 233 102 211
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.91 6.83 6.97 5.97 6.74 7.21 7.63 6.86 5.11 3.65 5.54
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 4.63 5.27 5.43 4.65 5.59 6.29 7.42 7.84 6.47 5.87 8.96
Price to Earnings (P/E)		 18.01 19.89 19.86 16.53 20.25 25.16 35.67 55.11 99.73 0.00 0.00
Dividend Yield		 1.71% 1.55% 1.57% 1.93% 1.80% 1.89% 1.92% 2.24% 3.16% 3.78% 2.58%
Earnings Yield		 5.55% 5.03% 5.03% 6.05% 4.94% 3.97% 2.80% 1.81% 1.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 3.46 3.99 4.24 3.71 4.25 4.35 4.46 3.96 3.03 2.57 3.65
Enterprise Value to Revenue (EV/Rev)		 5.42 6.01 6.09 5.30 6.22 7.03 8.31 8.95 7.77 6.97 10.12
Enterprise Value to EBITDA (EV/EBITDA)		 11.20 12.26 12.42 10.79 12.96 15.36 19.60 24.18 24.60 27.57 47.83
Enterprise Value to EBIT (EV/EBIT)		 15.46 16.25 16.08 13.76 16.79 20.89 29.00 42.68 57.49 105.62 402.34
Enterprise Value to NOPAT (EV/NOPAT)		 19.33 21.16 20.88 17.74 21.14 25.90 35.55 51.38 74.92 0.00 560.05
Enterprise Value to Operating Cash Flow (EV/OCF)		 11.92 14.00 14.14 13.19 16.75 18.55 24.03 28.88 32.94 34.18 53.79
Enterprise Value to Free Cash Flow (EV/FCFF)		 14.53 17.25 17.06 15.88 20.20 21.87 29.24 36.92 46.61 77.30 73.05
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.04 0.99 0.88 0.87 0.80 0.90 0.96 1.02 1.12 0.80 0.80
Long-Term Debt to Equity		 1.04 0.77 0.68 0.63 0.57 0.75 0.96 0.71 1.12 0.80 0.80
Financial Leverage		 1.14 1.09 1.01 0.98 0.87 0.90 0.88 0.90 0.88 0.77 0.81
Leverage Ratio		 2.65 2.62 2.55 2.50 2.41 2.45 2.44 2.43 2.42 2.27 2.32
Compound Leverage Factor		 2.49 2.48 2.40 2.37 2.19 1.94 1.79 1.50 -5.27 3.83 -1.00
Debt to Total Capital		 51.07% 49.72% 46.89% 46.58% 44.58% 47.40% 49.05% 50.58% 52.81% 44.30% 44.32%
Short-Term Debt to Total Capital		 0.00% 10.79% 10.87% 12.73% 13.01% 7.90% 0.00% 15.33% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 51.07% 38.92% 36.01% 33.84% 31.57% 39.51% 49.05% 35.25% 52.81% 44.30% 44.32%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 48.93% 50.28% 53.11% 53.42% 55.42% 52.60% 50.95% 49.42% 47.19% 55.70% 55.68%
Debt to EBITDA		 1.69 1.56 1.40 1.38 1.39 1.72 2.21 3.16 4.49 5.06 6.09
Net Debt to EBITDA		 1.62 1.50 1.34 1.32 1.32 1.63 2.10 3.01 4.10 4.36 5.46
Long-Term Debt to EBITDA		 1.69 1.22 1.08 1.00 0.98 1.43 2.21 2.20 4.49 5.06 6.09
Debt to NOPAT		 2.92 2.69 2.36 2.27 2.27 2.90 4.01 6.71 13.68 -1,478.38 71.34
Net Debt to NOPAT		 2.79 2.59 2.25 2.18 2.15 2.74 3.80 6.41 12.49 -1,275.76 63.93
Long-Term Debt to NOPAT		 2.92 2.10 1.81 1.65 1.61 2.41 4.01 4.67 13.68 -1,478.38 71.34
Altman Z-Score		 3.51 3.88 4.20 3.88 4.38 4.29 4.26 3.70 2.92 2.80 3.73
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.76 0.98 1.02 1.03 0.98 1.20 1.94 0.88 2.25 2.59 2.31
Quick Ratio		 0.91 0.49 0.54 0.58 0.51 0.58 0.93 0.40 1.08 1.27 1.12
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1,363 1,182 1,281 1,020 575 578 507 501 321 331 533
Operating Cash Flow to CapEx		 778.73% 470.49% 704.90% 656.23% 977.43% 565.05% 300.24% 65.47% 644.89% 365.72% 660.91%
Free Cash Flow to Firm to Interest Expense		 25.81 24.89 22.76 20.44 11.69 10.49 8.21 8.47 4.66 4.66 9.28
Operating Cash Flow to Interest Expense		 24.20 14.94 17.64 12.35 17.34 7.80 6.10 0.74 3.93 2.90 4.80
Operating Cash Flow Less CapEx to Interest Expense		 21.09 11.76 15.14 10.47 15.57 6.42 4.07 -0.39 3.32 2.11 4.07
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.50 0.52 0.54 0.55 0.53 0.47 0.41 0.34 0.30 0.28 0.27
Accounts Receivable Turnover		 7.65 7.10 6.72 6.30 6.64 6.23 5.14 4.00 4.22 4.80 4.55
Inventory Turnover		 2.74 2.52 2.51 2.43 2.27 2.00 1.82 1.63 1.50 1.48 1.56
Fixed Asset Turnover		 7.88 7.87 8.04 7.79 7.36 6.44 5.53 4.62 4.03 3.70 3.60
Accounts Payable Turnover		 8.08 7.39 9.62 8.65 9.43 8.65 10.10 8.95 9.13 10.35 10.76
Days Sales Outstanding (DSO)		 47.72 51.43 54.35 57.93 54.98 58.54 70.95 91.32 86.53 76.02 80.19
Days Inventory Outstanding (DIO)		 133.10 145.11 145.63 150.20 160.49 182.65 200.01 223.43 243.38 246.28 234.46
Days Payable Outstanding (DPO)		 45.16 49.38 37.96 42.19 38.69 42.18 36.13 40.80 39.97 35.26 33.91
Cash Conversion Cycle (CCC)		 135.66 147.16 162.03 165.94 176.78 199.01 234.83 273.95 289.93 287.04 280.74
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 12,611 12,720 12,591 12,788 12,495 12,338 12,259 12,413 12,195 11,937 11,749
Invested Capital Turnover		 0.62 0.65 0.68 0.69 0.68 0.61 0.53 0.44 0.39 0.36 0.35
Increase / (Decrease) in Invested Capital		 -745 -543 -572 -312 -117 -382 -332 -375 -300 -401 -510
Enterprise Value (EV)		 43,605 50,705 53,368 47,430 53,122 53,667 54,709 49,213 36,961 30,695 42,849
Market Capitalization		 37,305 44,499 47,608 41,611 47,708 47,987 48,856 43,076 30,798 25,836 37,958
Book Value per Share		 $11.48 $11.89 $12.53 $12.80 $13.09 $12.32 $11.93 $11.70 $11.23 $13.16 $12.71
Tangible Book Value per Share		 ($7.10) ($6.44) ($5.68) ($5.14) ($4.68) ($5.18) ($5.68) ($5.70) ($5.91) ($3.71) ($3.95)
Total Capital		 12,900 12,954 12,862 13,044 12,776 12,658 12,574 12,699 12,781 12,709 12,315
Total Debt		 6,589 6,440 6,031 6,076 5,695 6,000 6,168 6,423 6,750 5,630 5,458
Total Long-Term Debt		 6,589 5,042 4,632 4,415 4,033 5,000 6,168 4,477 6,750 5,630 5,458
Net Debt		 6,300 6,206 5,760 5,819 5,414 5,680 5,853 6,137 6,164 4,859 4,892
Capital Expenditures (CapEx)		 164 151 141 94 87 76 126 67 42 56 42
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 934 1,115 1,178 1,518 1,308 1,173 1,113 1,280 1,080 1,065 997
Debt-free Net Working Capital (DFNWC)		 1,223 1,349 1,449 1,775 1,589 1,493 1,428 1,566 1,666 1,836 1,563
Net Working Capital (NWC)		 1,223 -49 50 114 -74 494 1,428 -380 1,666 1,836 1,563
Net Nonoperating Expense (NNE)		 38 35 43 41 39 42 46 47 75 84 41
Net Nonoperating Obligations (NNO)		 6,300 6,206 5,760 5,819 5,414 5,680 5,853 6,137 6,164 4,859 4,892
Total Depreciation and Amortization (D&A)		 248 247 227 224 235 239 207 201 212 202 174
Debt-free, Cash-free Net Working Capital to Revenue		 11.60% 13.21% 13.44% 16.97% 15.31% 15.37% 16.90% 23.29% 22.69% 24.18% 23.54%
Debt-free Net Working Capital to Revenue		 15.19% 15.98% 16.53% 19.84% 18.60% 19.56% 21.68% 28.49% 35.01% 41.72% 36.91%
Net Working Capital to Revenue		 15.19% -0.58% 0.57% 1.27% -0.86% 6.47% 21.68% -6.92% 35.01% 41.72% 36.91%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.06 $1.10 $1.22 $1.23 $0.78 $0.29 $0.24 $0.15 ($0.10) ($0.30) ($0.09)
Adjusted Weighted Average Basic Shares Outstanding		 549.20M 550.40M 545.10M 543.10M 540.80M 542M 536.70M 536.70M 537.40M 537.30M 539.20M
Adjusted Diluted Earnings per Share		 $1.04 $1.10 $1.21 $1.21 $0.77 $0.29 $0.24 $0.14 ($0.10) ($0.29) ($0.09)
Adjusted Weighted Average Diluted Shares Outstanding		 555.40M 557.30M 551.40M 549.20M 546.50M 548M 542.80M 542M 537.40M 537.30M 539.20M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $1.10 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 547.80M 545.38M 544.33M 541.05M 540.39M 536.89M 536.51M 537.01M 537.82M 539.40M 539.68M
Normalized Net Operating Profit after Tax (NOPAT)		 623 640 711 709 459 183 177 127 24 -20 38
Normalized NOPAT Margin		 28.71% 28.68% 31.06% 31.46% 26.01% 13.82% 14.27% 10.90% 2.35% -2.07% 3.53%
Pre Tax Income Margin		 35.14% 35.91% 37.07% 36.98% 27.43% 15.06% 13.03% 7.86% -4.49% -17.34% -1.47%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 15.42 17.86 16.04 17.67 10.80 4.58 3.57 2.51 0.31 -1.41 0.64
NOPAT to Interest Expense		 11.70 13.45 12.60 14.18 9.31 3.56 2.83 2.13 0.31 -0.99 0.39
EBIT Less CapEx to Interest Expense		 12.31 14.68 13.54 15.79 9.03 3.20 1.54 1.39 -0.30 -2.20 -0.09
NOPAT Less CapEx to Interest Expense		 8.59 10.27 10.10 12.30 7.54 2.18 0.80 1.00 -0.30 -1.78 -0.34
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 30.90% 31.07% 31.34% 32.09% 36.71% 47.80% 69.00% 123.62% 315.22% -195,140.00% -676.35%
Augmented Payout Ratio		 75.87% 73.34% 68.51% 71.16% 73.57% 99.30% 135.76% 199.36% 471.92% -214,440.00% -692.39%

Key Financial Trends

Microchip Technology (NASDAQ: MCHP) reported mixed financial results over the recent quarters with some clear trends emerging across its income statements, balance sheets, and cash flow statements from 2022 through Q1 2026.

Income and Profitability:

  • Operating revenue showed growth in early 2024 and 2025, reaching over $1.0 billion in Q1 2026.
  • Gross profit margins improved in 2024 and early 2025 quarters, reaching about $736 million in Q2 2025 and $576 million in Q1 2026.
  • Net income swung from strong positive values in 2022 and 2023 (exceeding $400 million in several quarters) to losses in 2025 through Q1 2026, with Q1 2026 showing a net loss of approximately $18.6 million.
  • Operating income declined significantly from 2023 highs above $800 million to a loss of $15.8 million pre-tax income in Q1 2026.
  • Interest expense increased considerably in recent periods (~$57 million in Q1 2026), which, combined with declining operating income, negatively impacted profitability.

Cash Flow and Capital Expenditures:

  • Consistent strong operational cash flow generation, with net cash provided by operating activities around $275 million in Q1 2026 and higher in preceding quarters.
  • Significant cash outflows in financing activities, including large repayments of debt ($177 million in Q1 2026) and dividend payments ($271 million in Q1 2026), resulting in a net financing cash outflow.
  • Capital expenditures have been significant but stable, with purchases of property, plant & equipment around $41 to $150 million per quarter, indicating ongoing investments in infrastructure.
  • Net change in cash & equivalents has been negative recently, with a decrease of $205 million in Q1 2026, reflecting cash deployment in financing outflows exceeding cash generated from operations.

Balance Sheet and Financial Position:

  • Total assets have remained stable around $15-16 billion over recent quarters, indicating steady investment levels.
  • Long-term debt remains high at approximately $5.4 billion in Q1 2026, although it has fluctuated as debt is issued and repaid, creating financial leverage and pressure given rising interest expenses.
  • Inventory levels are substantial, about $1.17 billion in Q1 2026, reflecting either a buildup to meet demand or potential inventory management challenges.
  • Total liabilities around $8.1 billion in Q1 2026 with shareholders’ equity about $6.9 billion, maintaining a moderate leverage ratio but dependent on debt servicing capability given reduced profits.

Summary:

Microchip Technology demonstrated strong revenue and gross profit growth through 2022 and early 2023 but has experienced a troubling shift to losses starting mid-2025 and continuing into Q1 2026. The increase in interest costs amid a still significant debt load pressure earnings and cash flow. While operational cash flows remain solid, the company is deploying cash toward debt repayments and dividends. Investors should monitor Microchip’s ability to return to profitability and manage debt effectively, as sustained losses and high leverage could constrain financial flexibility.

08/31/25 07:22 PM ETAI Generated. May Contain Errors.

Financials Breakdown Chart

Frequently Asked Questions About Microchip Technology's Financials

When does Microchip Technology's financial year end?

According to the most recent income statement we have on file, Microchip Technology's fiscal year ends in March. Their fiscal year 2025 ended on March 31, 2025.

How has Microchip Technology's net income changed over the last 10 years?

Microchip Technology's net income appears to be on an upward trend, with a most recent value of -$500 thousand in 2025, falling from $365.33 million in 2015. The previous period was $1.91 billion in 2024. View Microchip Technology's forecast to see where analysts expect Microchip Technology to go next.

What is Microchip Technology's operating income?
Microchip Technology's total operating income in 2025 was $296.30 million, based on the following breakdown:
  • Total Gross Profit: $2.47 billion
  • Total Operating Expenses: $2.17 billion
How has Microchip Technology's revenue changed over the last 10 years?

Over the last 10 years, Microchip Technology's total revenue changed from $2.15 billion in 2015 to $4.40 billion in 2025, a change of 105.0%.

How much debt does Microchip Technology have?

Microchip Technology's total liabilities were at $8.30 billion at the end of 2025, a 10.0% decrease from 2024, and a 205.0% increase since 2015.

How much cash does Microchip Technology have?

In the past 10 years, Microchip Technology's cash and equivalents has ranged from $234 million in 2023 to $2.09 billion in 2016, and is currently $771.70 million as of their latest financial filing in 2025.

How has Microchip Technology's book value per share changed over the last 10 years?

Over the last 10 years, Microchip Technology's book value per share changed from 10.15 in 2015 to 13.16 in 2025, a change of 29.7%.


Related Companies

This page (NASDAQ:MCHP) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel